Antitrust Antitrust

Comment: Merging companies face EU approval delays as coronavirus slows regulator's work

By Nicholas Hirst, Lewis Crofts and Andrew Boyce
  • 16 Mar 2020 05:39
  • 10 Apr 2020 07:00

Billion-dollar mergers may have their approvals delayed as the Covid-19 pandemic poses unprecedented challenges to EU investigators charged with collecting market information and conducting probes while respecting companies’ procedural rights.

While there is little doubt the European Commission will bend over backwards to accommodate corporate needs, as it did in the wake of

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments

TAKE A FREE TRIAL

Latest News